Ryan Mac

I’m a New York Times reporter based in Los Angeles, covering corporate accountability across the global technology industry.What I Cover I write about large technology companies and the influential people who run them. I have reported in-depth pieces on companies including Meta, Twitter, TikTok and Apple, and often team up with colleagues for investigative stories. I am interested in the companies and people who have power and who use that power to shape society, business and politics. For years, I have critically covered powerful figures including Mark Zuckerberg, Peter Thiel and Elon Musk as they built their business empires and increased their influence. I also write about startups or other movers and shakers in tech. My Background I’ve covered the tech industry for more than a decade. I started my career at Forbes magazine as a reporter on the wealth team, which compiles the annual billionaires list. I then moved to cover tech startups and companies as a staff writer based in San Francisco. After that, I joined BuzzFeed News where I dug deeply into companies including Facebook, Google and Twitter. Journalistic Ethics As a Times journalist, I share the values and adhere to the standards of integrity outlined in The Times’s Ethical Journalism handbook. I’m committed to protecting my sources and writing fairly and accurately about the companies I cover. I do not invest in tech companies or accept gifts from businesses or individuals who might appear in my articles. I do not pay for information or interviews. To contact me securely, please reach out on Signal at +1-949-315-9364 or message me on our secure tip line. Or just shoot me an email. Email: ryan.mac@nytimes.com X: @rmac18 WhatsApp: +1-949-315-9364 Signal: +1-949-315-9364 LinkedIn: Ryan Mac Anonymous tips: nytimes.com/tips

62%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

50%

Examples:

  • The article does not provide any evidence or scientific backing for Elon Musk's claim that Telepathy will allow humans to control devices just by thinking.
  • The article implies that Neuralink has successfully implanted a device into a patient's brain without providing any details about the procedure, the patient or the results.

Conflicts of Interest

75%

Examples:

  • Ryan Mac writes about large technology companies and influential people who run them. He often covers Elon Musk and Neuralink, which are part of the global tech industry that he reports on.
  • The article does not disclose any potential conflicts of interest or sources of funding for Ryan Mac's reporting on Neuralink.

Contradictions

85%

Examples:

  • Neuralink received approval from FDA for human trials last May but does not provide any information about who was approved and what were the conditions of approval.
  • The title contradicts the body of the article by suggesting that Neuralink has already achieved a major breakthrough when no such information is provided.

Deceptions

60%

Examples:

  • The article does not provide any context or background information about Neuralink, its history, goals or challenges.
  • The article uses biased language such as 'powerful figures', 'use that power to shape society, business and politics' and 'I am always attracted to a good yarn' to create a positive image of Ryan Mac and his reporting on Neuralink.

Recent Articles

Neuralink's Telepathy: Revolutionizing Communication for the Disabled with Brain-Computer Interface Technology

Neuralink's Telepathy: Revolutionizing Communication for the Disabled with Brain-Computer Interface Technology

Broke On: Wednesday, 31 January 2024 Neuralink's Telepathy technology allows humans to control phones or computers just by thinking, with initial users being those who have lost the use of their limbs. The device interprets neural activity and enables faster communication than a speed typist or auctioneer, potentially transforming the lives of people with neurological conditions. Neuralink has implanted its first device in a human subject and received approval from the FDA to begin human trials last May. While some experts have expressed skepticism about the feasibility of Neuralink's ambitious goals, this technology has the potential to revolutionize communication and assistive devices.